http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. (HealthDay)—Colorectal cancer is the second leading cause of cancer death in the United States, but there are ways you can help prevent it, an expert says. http://medicalxpress.com/news/2013-03-colon-cancer-expert.html Cancer Fri, 08 Mar 2013 15:06:37 EST news281977587 (HealthDay)—A simple blood test might help predict a pancreatic cancer patient's chances of benefiting from chemotherapy, a small study suggests. http://medicalxpress.com/news/2013-01-blood-pancreatic-cancer-treatment.html Cancer Wed, 23 Jan 2013 16:20:01 EST news278177531 Survival for advanced stomach and oesophagael cancer patients increases by 40 per cent when treated with the chemotherapy drug, Docetaxel – providing evidence to prescribe it as a second-line treatment, according to the results of a Cancer Research UK trial presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal cancers symposium today (Wednesday). http://medicalxpress.com/news/2013-01-docetaxel-significantly-survival-incurable-gastric.html Cancer Wed, 23 Jan 2013 06:28:22 EST news278144892 A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to extend survival of late-stage pancreatic cancer patients compared to standard treatment. http://medicalxpress.com/news/2013-01-drug-combination-pancreatic-cancer-patient.html Cancer Tue, 22 Jan 2013 18:00:01 EST news278097991 A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic cancer patients compared to those receiving standard treatment, according to results of a Phase III clinical trial led by physicians from Scottsdale Healthcare's Virginia G. Cancer Center Clinical Trials, a partnership with the Translational Genomics Research Institute (TGen). http://medicalxpress.com/news/2012-11-phase-iii-worldwide-drug-patients.html Cancer Mon, 19 Nov 2012 13:14:23 EST news272553254 (HealthDay)—Gastrointestinal diseases account for substantial morbidity, mortality, and cost in the United States, according to research published in the November issue of Gastroenterology. http://medicalxpress.com/news/2012-10-burden-gastrointestinal-disease-substantial.html Cancer Mon, 29 Oct 2012 14:54:41 EST news270741268 New trial data showing improvements in the treatment of esophageal and gastrointestinal cancers were released today at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. http://medicalxpress.com/news/2012-09-advances-gastrointestinal-cancer-treatments.html Cancer Sat, 29 Sep 2012 05:16:08 EST news268114542 An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented today at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology in San Francisco by Mayo Clinic oncologist Axel Grothey, M.D., principal investigator of the trial in the United States. http://medicalxpress.com/news/2012-01-drug-survival-colorectal-cancer-patients.html Cancer Wed, 18 Jan 2012 03:47:37 EST news246080849